Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility
Saturday, January 31, 2026Eli Lilly and Company today announced plans to invest more than billion in a new manufacturing facility in the Lehigh Valley Pennsylvania The site will serve as Lillys newest injectable medicine and device manufacturing facility
Pharmaceutical Service Provider Vetter Pharma to Build New Manufacturing Site in Germany
Friday, January 30, 2026Vetter one of the worlds leading pharmaceutical service providers for the production of injectable drugs has confirmed its plans to build a stateoftheart production facility in the Saarland region of southwest Germany
Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development
Thursday, January 29, 2026Recent reports of Nipah virus NiV infections in West Bengal India have reignited global concern prompting public health authorities to prioritize research into this highmortality pathogen In response Sino Biological
Seamless Therapeutics Announces Global Research Collaboration with Lilly to Develop Programmable Recombinase-based Therapeutics for Hearing Loss
Thursday, January 29, 2026Seamless Therapeutics announced today that it has entered into a strategic global research collaboration and licensing agreement with Eli Lilly and Company Lilly to develop and commercialize programmable recombinasebased treatments
Bora Biologics Celebrates Opening of $30 Million San Diego Manufacturing Expansion
Thursday, January 29, 2026Biologics a contract drug manufacturing organization specializing in microbial and mammalianexpressed therapeutics celebrated the opening of its expanded FDAapproved manufacturing facility in San Diego
IXCells Biotechnologies and Rosebud Biosciences Partner to Advance Organoid-Based Models for Rare Diseases
Wednesday, January 28, 2026IXCells Biotechnologies iXCells a leading provider of human cellbased solutions and custom iPSC services and Rosebud Biosciences an innovator in organoid development and complex D biology today announced
Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
Wednesday, January 28, 2026Innovent Biologics Inc Innovent HKEX a worldclass biopharmaceutical company that develops manufactures and commercializes highquality medicines for the treatment of oncologic autoimmune
Boehringer Ingelheim’s investigational asset apecotrep delivers proteinuria reduction in Phase II kidney trial
Wednesday, January 28, 2026Boehringer Ingelheim today announced results from a week Phase II clinical trial evaluating apecotrep BI an oral potential firstinclass nonimmunosuppressive TRPC inhibitor for people with primary
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases
Tuesday, January 27, 2026Genethon a unique nonprofit gene therapy RD organization founded by the French Muscular Dystrophy Association AFMTelethon began the new year with an RD licensing deal for its gene therapy approach to Pompe disease
MetP Pharma’s Enabling Technology Creates a New Brain-Targeted GLP-1 Opportunity
Friday, January 23, 2026MetP Pharma AG a pioneer in nosetobrain drug delivery today announced new preclinical data demonstrating that its proprietary nasal technology achieves rapid dosedependent brain targeting of GLPbased drugs such as semaglutide while maintaining
